In PRAD, LCN2 expression was positively correlated with expression of CD244, CD48, LGALS9, TNFSF14, TMIGD2, VTCN1, TNFSF9, TNFRSF8, CD27, TNFRSF25, VSIR, TNFRSF4, CD40, TNFRSF15, CD86, and CD44 (Figure 5A). The gene discussed is TMIGD2; the disease is prostate adenocarcinoma.